AAAAAA
Results: 1-25/33
Authors:
NORUM J
LUNDE P
AASEBO U
HIMMELMANN A
Citation: J. Norum et al., MITOXANTRONE IN MALIGNANT PERICARDIAL-EFFUSION, Journal of chemotherapy, 10(5), 1998, pp. 399-404
Authors:
NORUM J
Citation: J. Norum, MAMMOGRAPHY SCREENING IN NORWAY - IS IT COST-EFFECTIVE, European journal of cancer, 34, 1998, pp. 413-413
Authors:
NORUM J
Citation: J. Norum, PREVENTION OF COLORECTAL-CANCER - A COST-EFFECTIVENESS APPROACH TO A SCREENING MODEL EMPLOYING SIGMOIDOSCOPY, Annals of oncology, 9(6), 1998, pp. 613-618
Authors:
NORUM J
Citation: J. Norum, PREVENTION OF COLORECTAL-CANCER - A COST-EFFECTIVENESS APPROACH TO A SCREENING MODEL EMPLOYING SIGMOIDOSCOPY, Annals of oncology, 9, 1998, pp. 165-165
Authors:
NORUM J
Citation: J. Norum, QUALITY-OF-LIFE IN COLORECTAL-CANCER PATIENTS TREATED WITH DOXORUBICIN AND A MULTIDRUG-RESISTANCE (MDR) MODULATOR (SDZ PSC-833) - A PILOT-STUDY, Anticancer research, 18(4C), 1998, pp. 2933-2936
Authors:
AASEBO U
NORUM J
SAGER G
SLORDAL L
Citation: U. Aasebo et al., INTRAPLEURALLY INSTILLED MITOXANTRONE IN METASTATIC PLEURAL EFFUSIONS- A PHASE-II STUDY, Journal of chemotherapy, 9(2), 1997, pp. 106-111
QUALITY-OF-LIFE IN DUKES-B AND DUKES-C COLORECTAL-CARCINOMA - THE INFLUENCE OF ADJUVANT CHEMOTHERAPY
Authors:
NORUM J
VONEN B
REVHAUG A
Citation: J. Norum et al., QUALITY-OF-LIFE IN DUKES-B AND DUKES-C COLORECTAL-CARCINOMA - THE INFLUENCE OF ADJUVANT CHEMOTHERAPY, Oncology Reports, 4(3), 1997, pp. 645-648
Authors:
NORUM J
OLSEN JA
REVHAUG A
VONEN B
Citation: J. Norum et al., ADJUVANT CHEMOTHERAPY IN DUKES-B AND DUKES-C COLORECTAL-CANCER - A COST-EFFECTIVENESS ANALYSIS, European journal of cancer, 33, 1997, pp. 1103-1103
Authors:
NORUM J
Citation: J. Norum, ADJUVANT CHEMOTHERAPY IN DUKES-B AND DUKES-C COLORECTAL-CANCER HAS ONLY A MINOR INFLUENCE ON PSYCHOLOGICAL DISTRESS, Supportive care in cancer, 5(4), 1997, pp. 318-321
Authors:
NORUM J
OLSEN JA
Citation: J. Norum et Ja. Olsen, A COST-EFFECTIVENESS APPROACH TO THE NORWEGIAN FOLLOW-UP PROGRAM IN COLORECTAL-CANCER, Annals of oncology, 8(11), 1997, pp. 1081-1087
Authors:
NORUM J
VONEN B
OLSEN JA
REVHAUG A
Citation: J. Norum et al., ADJUVANT CHEMOTHERAPY (5-FLUOROURACIL AND LEVAMISOLE) IN DUKES-B AND DUKES-C COLORECTAL-CARCINOMA - A COST-EFFECTIVENESS ANALYSIS, Annals of oncology, 8(1), 1997, pp. 65-70
Authors:
NORUM J
OLSEN JA
WIST EA
Citation: J. Norum et al., LUMPECTOMY OR MASTECTOMY - IS BREAST-CONSERVING SURGERY TOO EXPENSIVE, Breast cancer research and treatment, 45(1), 1997, pp. 7-14
Authors:
NORUM J
Citation: J. Norum, RADIOTHERAPY COSTS IN GLIOBLASTOMA - A COST-EFFECTIVE ANALYSIS, Oncology Reports, 3(4), 1996, pp. 777-780
Authors:
NORUM J
Citation: J. Norum, QUALITY-OF-LIFE (QOL) MEASUREMENT IN ECONOMICAL ANALYSIS IN CANCER - A COMPARISON OF THE EUROQOL QUESTIONNAIRE, A SIMPLE QOL-SCALE AND THE GLOBAL QOL MEASURE OF THE EORTC QLQ-C30, Oncology Reports, 3(4), 1996, pp. 787-791
Authors:
NORUM J
WIST EA
Citation: J. Norum et Ea. Wist, DELAY IN DIAGNOSIS AND TREATMENT OF BREAST-CANCER IN NORTHERN NORWAY, Oncology Reports, 3(3), 1996, pp. 571-574
Authors:
NORUM J
Citation: J. Norum, BREAST-CONSERVING SURGERY (BCS) IN NORTHERN NORWAY - MULTICENTER COOPERATIVE STUDIES AND TREATMENT PROTOCOLS ENSURE A HIGH TREATMENT STANDARD, International journal of oncology, 8(3), 1996, pp. 633-637
Authors:
NORUM J
WIST EA
Citation: J. Norum et Ea. Wist, QUALITY-OF-LIFE IN SURVIVORS OF HODGKINS-DISEASE, Quality of life research, 5(3), 1996, pp. 367-374
Authors:
NORUM J
ANGELSEN V
WIST E
OLSEN JA
Citation: J. Norum et al., TREATMENT COSTS IN HODGKINS-DISEASE - A COST-UTILITY ANALYSIS, European journal of cancer, 32A(9), 1996, pp. 1510-1517
Authors:
RISBERG T
WIST E
KAASA S
LUND E
NORUM J
Citation: T. Risberg et al., SPIRITUAL HEALING AMONG NORWEGIAN HOSPITALIZED CANCER-PATIENTS AND PATIENTS RELIGIOUS NEEDS AND PREFERENCES OF PASTORAL SERVICES, European journal of cancer, 32A(2), 1996, pp. 274-281
Authors:
NORUM J
WIST E
Citation: J. Norum et E. Wist, PSYCHOLOGICAL DISTRESS IN SURVIVORS OF HODGKINS-DISEASE, Supportive care in cancer, 4(3), 1996, pp. 191-195
Authors:
NORUM J
WIST E
JEROME CP
Citation: J. Norum et al., GD-DTPA ENHANCED MR-IMAGING IN THE MANAGEMENT OF RESIDUAL MEDIASTINALTUMORS IN MALIGNANT-LYMPHOMA AND THYMOMA, The Cancer journal, 9(1), 1996, pp. 56-57
Authors:
NORUM J
ANGELSEN V
Citation: J. Norum et V. Angelsen, CHEMOTHERAPY IN GASTRIC-CANCER - AN ECONOMIC-EVALUATION OF THE FAM (5-FLUOROURACIL, ADRIAMYCIN, MITOMYCIN-C) VERSUS ELF (ETOPOSIDE, LEUCOVORIN, 5-FLUOROURACIL) REGIMENS, Journal of chemotherapy, 7(5), 1995, pp. 455-459
Authors:
NORUM J
WIST EA
Citation: J. Norum et Ea. Wist, DELAY IN DIAGNOSIS AND TREATMENT OF BREAST-CANCER IN NORTHERN NORWAY - WHAT IS THE IMPACT, European journal of cancer, 31A, 1995, pp. 673-673
Authors:
NORUM J
NORDOY T
WIST E
Citation: J. Norum et al., TESTICULAR CANCER TREATED IN A MINOR GENERAL ONCOLOGY DEPARTMENT, European journal of cancer, 31A(3), 1995, pp. 293-295
Authors:
NORUM J
Citation: J. Norum, POSTMASTECTOMY RADIOTHERAPY, AXILLARY LYMPH-NODE DISSECTION AND ESTROGEN-RECEPTOR STATUS PREDICT PROGNOSIS, European journal of cancer, 31A(10), 1995, pp. 1714-1714